SCHEMBL2913408

SCHEMBL2913408

CC(C)(C)OC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])cn2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.43
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
MAPT P10636 5/20 0.39
RAB9A P51151 3/20 0.39
GAA P10253 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 2/20 0.39
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
DPP4 P27487 2/20 0.37
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK8 P45983 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912974 0.88 GSK3B (0.47) GSK3BKMT2AMEN1MAPTRAB9A
SCHEMBL2909829 0.86 HCRTR1 (0.41) CNR1CNR2
SCHEMBL1219461 0.85 GSK3B (0.49) GSK3BKMT2AMAPTALDH1A1LMNA
SCHEMBL2908173 0.85 GSK3B (0.47) GSK3BDPP4CNR1CNR2
SCHEMBL2910724 0.83 GSK3B (0.42) GSK3BKMT2AMEN1MAPTRAB9A
SCHEMBL2909927 0.83 GSK3B (0.49) GSK3BKMT2AMAPTALDH1A1MAPK1
SCHEMBL2913237 0.83 GSK3B (0.42) GSK3BKMT2AMEN1MAPTRAB9A
SCHEMBL2912944 0.83 GSK3B (0.42) GSK3BKMT2AMEN1MAPTRAB9A
SCHEMBL2909845 0.83 GSK3B (0.42) GSK3BKMT2AMEN1MAPTRAB9A
SCHEMBL2909838 0.80 GSK3B (0.47) GSK3BKMT2AMEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed